journal article·2024-09Open access

Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications

Duarte R. S. Almeida, João Ferreira Gil, Antonio José Guillot, Jiachen Li, Ricardo J. B. Pinto, Hélder A. Santos, Gil Gonçalves

Advanced Healthcare Materials· Volume 13· Issue 23

Abstract

Abstract Current research in cancer therapy focuses on personalized therapies, through nanotechnology‐based targeted drug delivery systems. Particularly, controlled drug release with nanoparticles (NPs) can be designed to safely transport various active agents, optimizing delivery to specific organs and tumors, minimizing side effects. The use of microfluidics (MFs) in this field has stood out against conventional methods by allowing precise control over parameters like size, structure, composition, and mechanical/biological properties of nanoscale carriers. This review compiles applications of microfluidics in the production of core‐shell NPs (CSNPs) for cancer therapy, discussing the versatility inherent in various microchannel and/or micromixer setups and showcasing how these setups can be utilized individually or in combination, as well as how this technology allows the development of new advances in more efficient and controlled fabrication of core‐shell nanoformulations. Recent biological studies have achieved an effective, safe, and controlled delivery of otherwise unreliable encapsulants such as small interfering RNA (siRNA), plasmid DNA (pDNA), and cisplatin as a result of precisely tuned fabrication of nanocarriers, showing that this technology is paving the way for innovative strategies in cancer therapy nanofabrication, characterized by continuous production and high reproducibility. Finally, this review analyzes the technical, biological, and technological limitations that currently prevent this technology from becoming the standard.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Innovative Microfluidic and Catalytic Techniques Innovation · 3D Printing in Biomedical Research · Microfluidic and Capillary Electrophoresis Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre for Mechanical Technology and Automation (TEMA) Mechanical Engineering Department University of Aveiro Aveiro 3810‐193 Portugal

Intelligent Systems Associate Laboratory (LASI) Guimarães 4800‐058 Portugal

Department of Pharmacy and Pharmaceutical Technology and Parasitology University of Valencia Ave. Vicent Andrés Estellés s/n Burjassot Valencia 46100 Spain

Department of Biomaterials and Biomedical Technology University Medical Center Groningen (UMCG) University of Groningen Groningen 9713 AV The Netherlands

CICECO—Aveiro Institute of Materials Chemistry Department University of Aveiro Aveiro 3810‐193 Portugal

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki Helsinki 00014 Finland

Funding

Fundação para a Ciência e a Tecnologia

References (100+)

Show source-provided references
1. Global Cancer Observatory “Cancer Today ”2023. (accessed: July 2023).
2. American Cancer Society2007. (accessed: July 2023).
3. 10.1007/s40820-020-00537-810.1007/s40820-020-00537-8 ↗
4. 10.3390/cancers1508225610.3390/cancers15082256 ↗
5. Powell K. · Nature · 2009
6. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
7. Bottaro E. · Micromachines (Basel) · 2017 · 8 · 1
8. 10.1016/j.carbon.2023.03.03410.1016/j.carbon.2023.03.034 ↗
9. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
10. Liu Y. · Small · 2022 · 18 · 1
11. 10.1016/j.jconrel.2013.07.02810.1016/j.jconrel.2013.07.028 ↗
12. 10.1021/cr100449n10.1021/cr100449n ↗
13. 10.1039/D0RA08607J10.1039/D0RA08607J ↗
14. 10.3390/mi1403049710.3390/mi14030497 ↗
15. 10.1021/acs.langmuir.5b0277310.1021/acs.langmuir.5b02773 ↗
16. 10.1016/S0169-409X(99)00041-110.1016/S0169-409X(99)00041-1 ↗
17. 10.1038/s41563-020-0755-z10.1038/s41563-020-0755-z ↗
18. 10.2217/nnm.16.510.2217/nnm.16.5 ↗
19. 10.1088/0957-4484/23/37/37560210.1088/0957-4484/23/37/375602 ↗
20. R.Ran H.Wang Y.Liu Y.Hui Q.Sun A.Seth D.Wibowo D.Chen C.‐X.Zhao 2018 1.10.1016/j.ejpb.2018.06.017 ↗
21. 10.1039/D1NR02065J10.1039/D1NR02065J ↗
22. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
23. 10.1016/j.biomaterials.2010.01.06510.1016/j.biomaterials.2010.01.065 ↗
24. 10.1016/j.ejpb.2010.12.02910.1016/j.ejpb.2010.12.029 ↗
25. 10.1016/j.cherd.2023.03.04910.1016/j.cherd.2023.03.049 ↗
26. 10.1007/s40005-022-00607-610.1007/s40005-022-00607-6 ↗
27. 10.1111/jphp.1309810.1111/jphp.13098 ↗
28. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
29. 10.3390/nano1007140310.3390/nano10071403 ↗
30. L.Bregoli J.Lysaght J.Reynolds A.Prina‐Mello Nanomedicine Applied to Translational Oncology: A Future Perspective on Cancer Treatment Short Title: Nanomedicine Applied to Translational Oncology2015.10.1016/j.nano.2015.08.006 ↗
31. 10.1016/j.jconrel.2016.01.02010.1016/j.jconrel.2016.01.020 ↗
32. 10.1039/D1NR00879J10.1039/D1NR00879J ↗
33. 10.1021/acsabm.9b0085310.1021/acsabm.9b00853 ↗
34. 10.1111/jvim.1259610.1111/jvim.12596 ↗
35. 10.1038/sj.bjc.660247910.1038/sj.bjc.6602479 ↗
36. 10.1111/j.1349-7006.2002.tb01217.x10.1111/j.1349-7006.2002.tb01217.x ↗
37. 10.1126/science.122633810.1126/science.1226338 ↗
38. Kang X. · Cancer Biol. Med. · 2015 · 12 · 362
39. 10.1021/ar300048p10.1021/ar300048p ↗
40. 10.1016/j.addr.2020.06.00310.1016/j.addr.2020.06.003 ↗
41. 10.1016/0014-5793(79)80281-110.1016/0014-5793(79)80281-1 ↗
42. 10.1016/j.addr.2018.03.00810.1016/j.addr.2018.03.008 ↗
43. 10.1186/2162-3619-1-1010.1186/2162-3619-1-10 ↗
44. He H. · Pharmaceutics · 2019 · 11
45. 10.1016/j.jconrel.2023.02.00610.1016/j.jconrel.2023.02.006 ↗
46. 10.1007/s13346-020-00724-510.1007/s13346-020-00724-5 ↗
47. 10.1021/nl801736q10.1021/nl801736q ↗
48. 10.1039/C8RA08972H10.1039/C8RA08972H ↗
49. 10.1021/bc500517k10.1021/bc500517k ↗
50. 10.1021/acs.molpharmaceut.7b0017710.1021/acs.molpharmaceut.7b00177 ↗
51. 10.1007/s00396-018-4311-110.1007/s00396-018-4311-1 ↗
52. 10.1021/acsami.9b2278110.1021/acsami.9b22781 ↗
53. 10.1021/acs.langmuir.1c0077810.1021/acs.langmuir.1c00778 ↗
54. 10.1016/j.ejps.2017.07.02010.1016/j.ejps.2017.07.020 ↗
55. 10.1039/D2NJ03279A10.1039/D2NJ03279A ↗
56. 10.1093/annonc/mdp31510.1093/annonc/mdp315 ↗
57. 10.1016/j.ijrobp.2013.02.00910.1016/j.ijrobp.2013.02.009 ↗
58. 10.1002/smsc.20210009510.1002/smsc.202100095 ↗
59. 10.1016/j.colsurfb.2015.10.00110.1016/j.colsurfb.2015.10.001 ↗
60. D.Chouhan T.Lohe P. K.Samudrala B. B.Mandal 2018 1801092 1.
61. 10.3390/pharmaceutics1401014110.3390/pharmaceutics14010141 ↗
62. Hua S. · Front Pharmacol · 2013 · 4
63. 10.3389/fphar.2015.0028610.3389/fphar.2015.00286 ↗
64. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
65. 10.1002/btm2.1012510.1002/btm2.10125 ↗
66. Kashapov R. · Int. J. Mol. Sci. · 2021 · 22
67. 10.1093/oxfordjournals.annonc.a01071710.1093/oxfordjournals.annonc.a010717 ↗
68. 10.1080/21655979.2021.201290710.1080/21655979.2021.2012907 ↗
69. National Cancer Institute Current Nanotechnology Treatments 2023. (accessed: September 2023).
70. Rodríguez F. · Biomolecules · 2022 · 12
71. 10.1002/apj.240710.1002/apj.2407 ↗
72. 10.1016/j.jddst.2018.12.00910.1016/j.jddst.2018.12.009 ↗
73. 10.1016/j.addr.2017.08.00310.1016/j.addr.2017.08.003 ↗
74. 10.1039/D3NR00280B10.1039/D3NR00280B ↗
75. 10.1016/j.cis.2021.10254110.1016/j.cis.2021.102541 ↗
76. 10.1016/j.supflu.2015.02.03310.1016/j.supflu.2015.02.033 ↗
77. 10.1016/j.nantod.2016.04.00610.1016/j.nantod.2016.04.006 ↗
78. 10.1016/j.addr.2011.04.00510.1016/j.addr.2011.04.005 ↗
79. 10.1016/j.ijpharm.2017.08.06410.1016/j.ijpharm.2017.08.064 ↗
80. 10.1039/C9RA10857B10.1039/C9RA10857B ↗
81. Vladisavljević G. T. · Micromachines (Basel) · 2017 · 8
82. 10.1038/s41598-023-36672-610.1038/s41598-023-36672-6 ↗
83. 10.1021/acsnano.3c0111710.1021/acsnano.3c01117 ↗
84. 10.3390/genes906028510.3390/genes9060285 ↗
85. 10.1038/nature0416310.1038/nature04163 ↗
86. Chhabra R. P. · 2018 · 529
87. 10.1146/annurev.bioeng.4.112601.12591610.1146/annurev.bioeng.4.112601.125916 ↗
88. 10.1016/j.matpr.2020.09.41710.1016/j.matpr.2020.09.417 ↗
89. 10.1088/0022-3727/46/11/11400210.1088/0022-3727/46/11/114002 ↗
90. 10.1016/j.colsurfa.2014.04.00610.1016/j.colsurfa.2014.04.006 ↗
91. 10.1007/s10404-019-2269-z10.1007/s10404-019-2269-z ↗
92. 10.1016/j.jtice.2021.07.04510.1016/j.jtice.2021.07.045 ↗
93. Shen C. · Micromachines (Basel) · 2020 · 11
94. 10.1016/j.memsci.2008.01.02310.1016/j.memsci.2008.01.023 ↗
95. 10.1016/j.rineng.2023.10112510.1016/j.rineng.2023.101125 ↗
96. 10.1021/nn901433u10.1021/nn901433u ↗
97. 10.1021/nn403906310.1021/nn4039063 ↗
98. 10.1016/j.jconrel.2023.04.02410.1016/j.jconrel.2023.04.024 ↗
99. 10.1016/j.carbpol.2021.11802710.1016/j.carbpol.2021.118027 ↗
100. 10.1021/acs.langmuir.3c0018310.1021/acs.langmuir.3c00183 ↗